Minerva Neurosciences, Inc.NERVNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank29
3Y CAGR-4.1%
5Y CAGR-11.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-4.1%/yr
vs -11.0%/yr prior
5Y CAGR
-11.6%/yr
Recent acceleration
Acceleration
+6.9pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
6 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$9.34M-6.1%
2024$9.95M-4.5%
2023$10.41M-1.6%
2022$10.58M-20.6%
2021$13.33M-22.9%
2020$17.29M-2.5%
2019$17.74M+5.3%
2018$16.84M+54.3%
2017$10.91M+11.9%
2016$9.75M-